Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Teva Pharmaceutical Industries ADR (NY: TEVA )

17.43 -1.34 (-7.14%)
Official Closing Price Updated: 7:00 PM EST, Nov 6, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Teva Pharmaceutical Industries ADR

< Previous 1 2 3 4 5 6 7 8 9
...
24 25 Next >
Stocks Mixed Ahead Of Big Tech Earnings
Stocks are a mixed bag this afternoon, following the start of the Federal Reserve's two-day policy meeting. 
Via Talk Markets
Topics Economy
Exposures Interest Rates
A Preview Of Teva Pharmaceutical Indus's Earnings
Via Benzinga
Tech Titans Microsoft, Apple Lead 'Magnificent Seven' Earnings Wave This Week: Can Mega-Caps Ignite Market Optimism?
An analyst sees the Satya Nadella-led company's earnings to be the key barometer for AI spending. 
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
What To Know About UBS's Upgrade of Teva Pharmaceutical Indus
Via Benzinga
Enphase Energy To Rally Over 35%? Here Are 10 Top Analyst Forecasts For Tuesday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. 
Via Benzinga
In-Depth Examination Of 4 Analyst Recommendations For Teva Pharmaceutical Indus
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Healthcare Giant Eli Lilly Under FDA Lens Again For Manufacturing Lapses
Eli Lilly faces FDA scrutiny with eight deficiencies at its Branchburg plant, raising concerns on Emgality's manufacturing. 
Via Benzinga
Exposures Product Safety
Why Big Pharma Led By Merck, Sanofi, Teva Are Pouring Billions Into A New Immunology Space
The companies are working on blocking TL1A, a protein tied to inflammatory bowel disease. 
Via Investor's Business Daily
3 No-Brainer Stocks to Buy With $20 Right Now
You don't need a mountain of cash to begin building your wealth on Wall Street. 
Via The Motley Fool
Cramer Says This Major Healthcare Stock Is 'Ridiculously Cheap And Doing So Many Great Things'
On CNBC’s "Mad Money Lightning Round," Jim Cramer said he likes Realty Income (NYSE: O) and recommends staying with it. "It’s a very steady story," he noted. 
Via Benzinga
Teva to Host Conference Call to Discuss Fourth Quarter and Full Year 2023 Financial Results and 2024 Financial Guidance at 8 a.m. ET on January 31, 2024
From Teva Pharmaceutical Industries Limited
Via Business Wire
Teva to Present at the 42nd Annual J.P. Morgan Healthcare Conference
From Teva Pharmaceutical Industries Limited
Via Business Wire
My 5 Largest Portfolio Holdings for 2024
This mix of growth and value stocks appears set to outperform -- and hopefully makes me a lot richer in the process. 
Via The Motley Fool
Teva and Biolojic Design Announce Exclusive License Agreement for the Development of a Therapeutic Antibody for Atopic Dermatitis and Asthma
From Teva Pharmaceutical Industries Limited
Via Business Wire
New Post Hoc Phase 3 Data Analysis Shows AJOVY® (fremanezumab) Reduced Migraine Attacks in Adults with Migraine and Co-morbid Obesity
From Teva Pharmaceutical Industries Limited
Via Business Wire
Venue Turmoil: Pharma Companies Oppose States' Bid to Relocate Price-Fixing Cases
Major pharmaceutical firms, including generic manufacturers such as Teva Pharmaceutical Industries Limited (NYSE: TEVA), Sandoz Group (OTC:  
Via Benzinga
Supreme Court Decision Looms Over Purdue Pharma's $6B Opioid Settlement And Sackler Family Immunity
The fate of a $6 billion bankruptcy settlement involving Purdue Pharma, the maker of the powerful and addictive pain medication OxyContin, hangs in th 
Via Benzinga
Topics Bankruptcy
Exposures Financial Legal
MarketBeat Week in Review – 11/27 - 12/1
Stocks closed the week at or near yearly highs after subdued inflation numbers suggest the Federal Reserve will continue to pause on raising rates 
Via MarketBeat
Topics Economy Stocks
Exposures Economy Interest Rates US Equities
Teva Completes Closing of Exclusive Collaboration Deal to Deliver Inflammatory Bowel Disease Treatment
From Teva Pharmaceutical Industries Limited
Via Business Wire
Teva Pharma is the way to play the re-rise of generic drugs
Generic and specialty pharmaceutical company, Teva Pharmaceutical's stock, has underperformed for years, but a potential spinoff may be a catalyst for growth 
Via MarketBeat
Israel And Hamas Agree To Extend Truce By 2 Days; Elon Musk Wishes For World Peace After Visiting Israel
Israel and Hamas extend temporary truce for two more days. US Secretary of State and Elon Musk visit Israel to discuss situation. UN Secretary-General hopes pause allows for increased humanitarian aid... 
Via Benzinga
Ituran Location and Control Posts Q3 Results, Joins Crown Castle, Shopify And Other Big Stocks Moving Higher On Monday
U.S. stocks traded mostly lower, with the Dow Jones falling around 50 points on Monday. Shares of Ituran Location and Control Ltd. (NASDAQ: ITRN) gained during Monday’s session after the company... 
Via Benzinga
Topics Stocks
Exposures US Equities
CrowdStrike To Rally More Than 16%? Here Are 10 Top Analyst Forecasts For Monday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. 
Via Benzinga
3 Resilient Stocks with Massive Potential to Boost Your Wealth
These three stocks with massive potential can make patient investors fabuslously wealthy as they come roaring back to life. 
Via InvestorPlace
Teva to Present at the 6th Annual Evercore ISI HealthCONx Conference
From Teva Pharmaceutical Industries Limited
Via Business Wire
2 overlooked stocks that crushed earnings but traded lower
As the third quarter 2023 earnings season ends, it's worth looking back to see which stocks may have been overlooked or mispriced on their results 
Via MarketBeat
Exposures Product Safety
Resilient Large Cap Israeli- Domiciled U.S. Exchange-Listed Stocks Up 16.5% Last Week
After an unsurprising drop at the beginning of the war, the 15 large-cap Israeli- domiciled companies listed on U.S. stock exchanges have bounced back and are now up 1.2%, on average, since Oct.7.... 
Via Talk Markets
Teva Announces Approval of a Generic Version of Forteo® (teriparatide injection), in the U.S.
From Teva Pharmaceutical Industries Limited
Via Business Wire
Tuesday Talk: What's Going On?
The stock market rallied last week. The S&P 500 closed 51 points higher, the Dow closed 191 points higher, and the Nasdaq Composite closed 284 points higher. But is the rally real? 
Via Talk Markets
Topics Stocks
Exposures US Equities
< Previous 1 2 3 4 5 6 7 8 9
...
24 25 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
Copyright © 1995-2016 Knight Sac Media. All rights reserved.Stock quotes are delayed at least 15 minutes - See Terms of Use.